We observed that inhibition of EphB4-ephrin-B2 signaling in vivo significantly reduced tumor growth and decreased the infiltration of Tregs, TAMs, and increased infiltration and activation of Teffector cells, without affecting CD4 T cell numbers. Here, EFNB2 is linked to neoplasm.